Inventor · disambiguated record
Robert Epple
Also filed as: EPPLE ROBERT
17 granted patents·23 pending applications·49 citations·filing 2002–2021
91Inventor score
Top patents by PatentIndex Score
40 records- 0183US7307095B2Inhibitors of cathepsin SIRM LLC·Filed 2007·Granted Dec 11, 2007·4 cites·18 claims
- 0282US8153635B2Compounds and compositions as modulators of GPR119 activityALPER PHILLIP B·Filed 2008·Granted Apr 10, 2012·7 cites·17 claims
- 0381US8258156B2Compounds and compositions as modulators of GPR119 activityALPER PHILLIP B·Filed 2011·Granted Sep 4, 2012·6 cites·8 claims
- 0480US7109243B2Inhibitors of cathepsin SIRM LLC·Filed 2004·Granted Sep 19, 2006·14 cites·19 claims
- 0579US10450273B2N-(pyridin-2-yl)pyridine-sulfonamide derivatives and their use in the treatment of diseaseNOVARTIS AG·Filed 2017·Granted Oct 22, 2019·3 cites·43 claims
- 0672US8362050B2Compounds and methods for modulating G protein-coupled receptorsIRM LLC·Filed 2009·Granted Jan 29, 2013·1 cites·11 claims
- 0770US7745445B2Compounds and compositions as PPAR modulatorsIRM LLC·Filed 2005·Granted Jun 29, 2010·1 cites·5 claims
- 0869US9440957B2Compounds and compositions for modulating EGFR ActivityLELAIS GERALD·Filed 2013·Granted Sep 13, 2016·3 cites·21 claims
- 0968US8575168B2Compounds and compositions as modulators of GPR119 activityAZIMIOARA MIHAI·Filed 2010·Granted Nov 5, 2013·4 cites·13 claims
- 1065US8334288B24-phenoxymethylpiperidines as modulators of GPR119 activityEPPLE ROBERT·Filed 2009·Granted Dec 18, 2012·2 cites·7 claims
- 1164US11066369B2N-(pyridin-2-yl)pyridine-sulfonamide derivatives and their use in the treatment of diseaseNOVARTIS AG·Filed 2019·Granted Jul 20, 2021·0 cites·24 claims
- 1263US7173051B2Inhibitors of cathepsin SIRM LLC·Filed 2004·Granted Feb 6, 2007·2 cites·24 claims
- 1362US7384970B2Inhibitors of cathepsin SIRM LLC·Filed 2004·Granted Jun 10, 2008·2 cites·15 claims
- 1459US2008242671A1Inhibitors of cathepsin sIRM LLC·Filed 2008·Application pending·0 cites
- 1555US2023365571A1COMPOUNDS AND COMPOSITIONS AS Sppl2a INHIBITORSNOVARTIS AG·Filed 2021·Application pending·0 cites
- 1653US2010022515A1Compounds and compositions as modulators of gpr119 activityIRM LLC·Filed 2008·Application pending·0 cites
- 1750US2011172244A1Compounds and compositions as modulators of gpr119 activityIRM LLC·Filed 2009·Application pending·0 cites
- 1849US2011190263A1Compounds and compositions as modulators of gpr119 activityIRM LLC·Filed 2009·Application pending·0 cites
- 1949US2011166176A1Compounds and compositions as modulators of gpr119 activityIRM LLC·Filed 2009·Application pending·0 cites
- 2049US2011263557A1Compounds and compositions as modulators of gpr119 activityIRM LLC·Filed 2009·Application pending·0 cites
- 2148US2012196844A1Compounds and compositions as modulators of gpr119 activityALPER PHILLIP B·Filed 2012·Application pending·0 cites
- 2248US2013096165A1Compounds and methods for modulating g protein-coupled receptorsIRM LLC·Filed 2012·Application pending·0 cites
- 2347US7034147B2Nucleoside analog librariesIRM LLC·Filed 2003·Granted Apr 25, 2006·0 cites·18 claims
- 2447US2022127247A1N-(pyridin-2-yl)pyridine-sulfonamide derivatives and their use in the treatment of diseaseNOVARTIS AG·Filed 2020·Application pending·0 cites
- 2546US2010120807A1Compounds and compositions as modulators of gpr119 activityIRM LLC·Filed 2008·Application pending·0 cites
- 2645US2004006176A1Nucleoside analog librariesIRM LLC·Filed 2002·Application pending·0 cites
- 2744US7750032B2Compounds and compositions as PPAR modulatorsIRM LLC·Filed 2006·Granted Jul 6, 2010·0 cites·9 claims
- 2844US2022033407A1N-(pyridin-2-ylsulfonyl)cyclopropanecarboxamide Derivatives and their Use in the Treatment of DiseaseNOVARTIS AG·Filed 2019·Application pending·0 cites
- 2944US2009012097A1Polycyclic 1,2,3,4-Tetrahydro-Isoquinoline Derivatives and Compositions Comprising Them As Ppar ModulatorsIRM LLC·Filed 2007·Application pending·0 cites
- 3043US2010022592A1Thiazole derivatives as modulators of g protein-coupled receptorsIRM LLC·Filed 2008·Application pending·0 cites
- 3143US2009137610A1Spiro imidozole derivatives as ppar modulatorsIRM LLC·Filed 2007·Application pending·0 cites
- 3242US8394841B2Compounds and methods for modulating G protein-coupled receptorsEPPLE ROBERT·Filed 2008·Granted Mar 12, 2013·0 cites·6 claims
- 3341US2008292608A1Compounds and Compositions as Ppar ModulatorsIRM LLC·Filed 2006·Application pending·0 cites
- 3441US2009192203A1Compounds and compositions as ppar modulatorsIRM LLC·Filed 2006·Application pending·0 cites
- 3539US2009088368A1Compositions comprising them as ppar modulatorsIRM LLC·Filed 2007·Application pending·0 cites
- 3639US2010048453A1Oxazole and thiazole ppar modulatorIRM LLC·Filed 2006·Application pending·0 cites
- 3738US7820705B2Compounds and compositions as PPAR modulatorsIRM LLC·Filed 2005·Granted Oct 26, 2010·0 cites·7 claims
- 3838US2015152083A1Compounds and Compositions for Modulating EGFR ActivityLELAIS GERALD·Filed 2013·Application pending·0 cites
- 3938US2007244130A1Compounds and Compositions as Ppar ModulatorsIRM LLC·Filed 2005·Application pending·0 cites
- 4038US2007203155A1Compounds And Compositions As Ppar ModulatorsIRM LLC·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Robert Epple files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →